ISRG vs. ABT: Which MedTech Giant Is the Smarter Investment Now?

The article argues ISRG’s expanding robotic surgery ecosystem and innovation pipeline position it ahead of Abbott for investors targeting stronger long-term MedTech growth. While no specific financial metrics or guidance figures are cited, the thrust is constructive on ISRG’s relative fundamentals versus Abbott.

Analysis

The article argues ISRG’s expanding robotic surgery ecosystem and innovation pipeline position it ahead of Abbott for investors targeting stronger long-term MedTech growth. While no specific financial metrics or guidance figures are cited, the thrust is constructive on ISRG’s relative fundamentals versus Abbott.